Drug trial aims to stop dangerous fluid buildup after liver cancer surgery
NCT ID NCT02799212
Summary
This study tested whether giving the drug somatostatin after liver cancer surgery could prevent a serious complication called ascites, which is fluid buildup in the abdomen. It involved 179 patients with liver cancer and underlying liver disease who had surgery to remove part of their liver. The goal was to see if this already-approved drug could reduce complications, speed up recovery, and shorten hospital stays.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHM - Hôpital de la Timone
Marseille, France
-
APHP - Hôpital Beaujon
Clichy, France
-
CHRU Lille - Hopital Huriez
Lille, France
-
CHU Rennes - Hôpital Pontchaillou
Rennes, France
-
CHU de Bordeaux - Hôpital Haut Lévèque
Pessac, France
-
CHU de Toulouse - Hopital Rangueil
Toulouse, France
-
Hospices Civils de Lyon - Hôpital de la Croix Rousse
Lyon, 69004, France
Conditions
Explore the condition pages connected to this study.